Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06898996 · ClinicalTrials.gov registry record
FITting Non-invasive Tests in Lynch Syndrome Surveillance
A clinical trial of Colorectal Cancer, sponsored by University of Chicago.
- Recruiting
- Registry status
- 400
- Enrollment target
- 3
- Study locations
NCT06898996 is a study of Colorectal Cancer that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 400 participants, below the 1,510-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (74% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT06898996, a study of Colorectal Cancer, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this clinical study is to evaluate the accuracy of the fecal immunochemical test (FIT) in comparison to colonoscopy in patients with Lynch Syndrome (LS) who are undergoing colonoscopy surveillance.
Conditions Studied
Interventions
- OTHER Fecal immunochemical test
Study Locations (3)
Illinois
- The University of Chicago Medical Center - Chicago
Michigan
- University of Michigan - Ann Arbor
New York
- Columbia University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2025-07-10 |
| Est. Completion | 2029-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06898996
The ClinicalTrials.gov registry entry for NCT06898996 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,510-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (74% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Fecal immunochemical test is the first listed.
NCT06898996 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Illinois, Michigan, New York.
Frequently Asked Questions
What is clinical trial NCT06898996 about?
NCT06898996 is a clinical study titled "FITting Non-invasive Tests in Lynch Syndrome Surveillance". The purpose of this clinical study is to evaluate the accuracy of the fecal immunochemical test (FIT) in comparison to colonoscopy in patients with Lynch Syndrome (LS) who are undergoing colonoscopy surveillance.
What is the current status of trial NCT06898996?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2025-07-10. Estimated completion is 2029-07-01.
What conditions does trial NCT06898996 study?
This clinical trial studies the following conditions: Colorectal Cancer.
What interventions are being tested in trial NCT06898996?
The interventions under investigation include: Fecal immunochemical test (OTHER).
Who is sponsoring clinical trial NCT06898996?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06898996 being conducted?
This trial has 3 study locations across Illinois, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.